Elliott Jeter
Managing Director, Health Care Valuation Services
Featured
Featured
Featured
Insights & Resources
A recent U.S. complaint highlights the growing need for health care systems to ensure physician compensation aligns with fair market value to avoid compliance risks.
Ardent Health’s recent IPO highlights the company’s unique qualities, though it creates valuation comparability challenges for joint ventures and leased facilities.
The home health and hospice sectors are facing significant challenges with personal care emerging as the key sector for mitigating risk.
Explore Weaver's insights on the current health care deal volume decline and valuation.
Recent trends in financial performance & provider productivity show challenges facing medical groups related to practice margins. What does it mean for valuations?
In any health care segment, buyer concentration can have an effect on valuation pricing and is one of the key macro-dynamics that should be considered in a health care valuation analysis.
Get ahead of the curve by looking back at emerging trends in 2023 that are likely to impact health care valuation in 2024 and beyond. Download Weaver Insights now.
Changing Medicare populations, staffing shortages and other issues create challenges for valuations of home health care agencies.
Demographics Signal a Long-Term Payor Mix Shift: Commercial Mix Erosion Could Signal Valuation Implications.
Considerations for current and future valuations of for-profit freestanding inpatient rehabilitation facilities.
More patients choose retail health clinics and urgent care centers for health care needs. This article discusses how this may affect other providers.
How will higher demand for outpatient surgery as indicated by market signals affect health care valuations? Weaver's professionals highlight the implications.
Weaver’s valuation professionals analyzed physician practice transaction volume data to examine the potential impact on valuations.
Nurse shortages have skewed the normal percentage mix towards agency resulting in increased hourly unit costs. Learn about the health care valuation implication.
Get ahead of the curve by looking back at emerging trends in 2022 that are likely to impact health care valuation in 2023 and beyond. Download Weaver Insights now.
Health care services transaction volume decreased significantly in 2022, decelerating from a blistering pace in 2021.
What are the valuation takeaways from the percentage of the U.S. population without health insurance being at record lows?
Learn why hospitals are pulling every lever to control expenses as statistics show a significant increase in total costs due to inflation and labor shortages.
With the post-2021 recovery in health care, profits for providers are expected to continue to rise. What are the implications for health care valuations?
Learn why valuators should evaluate the impact of investment, or partnership, in telehealth infrastructure & other outpatient programs.
Urgent care operators have invested a record amount of capital into opening new sites in 2022. What is the impact on health care valuations?
Private equity firms and strategic buyers invested a record amount of capital into health care businesses which attracted new participants to enter the space.
As the demand for contract and travel registered nurses has grown, so have the related costs. What is the impact on health care valuations?
Estimates of future outpatient surgery migration indicate that ASC industry revenue and profits will increase significantly. Find out why.
Get ahead of the curve by looking back at emerging trends in 2021 that are likely to impact health care valuation in 2022 and beyond.
Read about some of the impacts of increased hospital employment and accelerated retirements resulting in shortages of replacement physician investors.
The urgent care industry has been experiencing accelerated patient visit volume into 2021, continuing trends started in 2020.
Many business valuations begin with calculating a multiple of EBITDA (earnings before interest, taxes, depreciation, and amortization). In health care, however, valuators should deliberate just when and how to apply general valuation EBITDA transaction multiples for fair market value opinions.
Commentary from publicly traded Managed Care Organizations (MCOs) regarding their insurance spend expectations can be an excellent source of macroeconomic data for health care valuation professionals when projecting performance for provider entities.
Transactions for large hospice providers are yielding historically high multiples of EBITDA and revenue.